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Central nervous system injuries usually produce motor impairments that are 
exacerbated by pathologically altered muscle tone. Abnormal muscle tone interferes with 
voluntary movement and is associated with loss of dexterity. Prior work in our laboratory 
demonstrated that 30-second trans-spinal direct current (DC) stimulation can temporarily modify 
muscle tone in anesthetized spastic mice after spinal cord injury (SCI). These experiments 
described DC-induced muscle tone responses to be polarity-dependent. That is, anodal 
stimulation (current passed from the lumbar spine to sciatic nerve) decreased muscle tone, and 
cathodal stimulation (current passed from the sciatic nerve to the lumbar spine) increased it. The 
present study investigates the therapeutic potential of noninvasive trans-spinal DC stimulation 
(tsDCS) to modulate spasticity in awake mice with SCI. The study aims to investigate the 
following: 1- The effects of short-term tsDCS and repeated-sessions of tsDCS on muscle tone 
and on skilled and unskilled locomotion. 2- The long-term modulatory effects of tsDCS on the 
stretch reflex of the triceps surae muscle (TS), using the rate-dependent depression (RDD) of 






pharmacological agents, including gabapentin, morphine and MK-801. To assess spasticity in the 
awake SCI mouse model, an innovative computer-controlled stretch apparatus with a mouse 
holder was designed and constructed in our laboratory. The design permitted spasticity 
assessment by stretching the TS at different speeds, while the animal received noninvasive 
tsDCS treatment. The treatment protocol consisted of seven consecutive daily tsDCS sessions 
(20 min/day), followed by spasticity evaluations for four weeks after stimulation ended. The 
mice were also evaluated for two different types of locomotion: 1- unskilled locomotion using 
the DigiGait treadmill system, and 2- skilled locomotion using a computer-controlled ladder 
wheel, constructed in our laboratory. Results show that anodal tsDCS significantly reduced 
several indices of spasticity during treatment, and for at least four weeks after simulation ended. 
Additionally, anodal-tsDCS treated animals exhibited significantly improved unskilled and 
skilled locomotion, and significant increase in RDD. Anodal treatment also improved the 
spasticity-reducing effects of gabapentin and MK-801, and decreased morphine-induced rigidity. 
In conclusion, these results show anodal tsDCS to be therapeutically effective in ameliorating 
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Chapter 1  – Introduction  
Overview of Muscle Tone Abnormalities and Management 
Hypertonia is a common muscle tone abnormality associated with spinal cord injury 
(SCI). Clinically, muscle tone is determined by the amount of resistance conveyed by the muscle 
during a passive stretch. A normal muscle typically possesses a healthy level of resting muscle 
tone, which is usually active in the background of normal voluntary contractions. A normal level 
of muscle tone is essential for coordination, preparedness to initiate movement, and maintenance 
of the proper position of body joints at rest. While low muscle tone, hypotonicity, is a condition 
marked by reduced resistance to a passive muscle stretch, hypertonicity is an increase in muscle 
tone associated with an enhanced stretch reflex (Katz and Rymer, 1989). And spasticity is a 
velocity dependent sensorymotor system disorder, recognized when increases in the stretch speed 
lead to subsequent increases in muscle resistance, and vice versa (Lance, 1980). The exaggerated 
tendon jerks associated with spasticity are attributed to hyperexcitability of spinal interneurons 
(Elbasiouny et al., 2010), and alpha motor neurons (Mayer, 1997). Hypertonicity can vary greatly 
in severity, from mild muscle stiffness to a painfully and debilitating sustained muscle contraction 
(Adams and Hicks, 2005). When spasticity interferes with functional movement after SCI, 
medications are usually prescribed. However, pharmacologic treatments of spasticity come with a 
wide variety of side effects. For example, Botox, a well-known and widely-used spasticity drug, is 
actually botulinum, an extremely potent biological toxin, which acts on the motor neurons via 
inhibiting acetylcholine release. Botox administration is an invasive procedure that require 
muscular injections, provides only temporary spasticity control, and has been reported to produce 






cure for spasticity (Gracies et al., 1997). Therefore, for the past few decades, a large body of 
research has focused on testing safer methods to control spasticity.  
Direct Current Stimulation Affects Muscle Tone 
One promising approach has been the use of direct current (DC) to improve the 
functional motor activities of patients with spasticity. Recent work supports the modulatory effects 
of DC stimulation on CNS activity (Aguilar et al., 2011; Ahmed, 2016; Ranieri et al., 2012; Song 
and Martin, 2017). The support is compelling in humans (Cogiamanian et al., 2008; Nitsche and 
Paulus, 2001), and animals (Ahmed, 2014b; Bolzoni and Jankowska, 2015). For example, when 
applied transcranially, anodal DC current significantly improved motor control functions in stroke 
patients (Boggio et al., 2007), and reduced spasticity for at least two days after stimulation stopped 
in children and adolescents with cerebral palsy (Aree-uea et al., 2014). Additionally, animal 
studies demonstrated the ability of DC stimulation to induce plastic changes in CNS circuitry 
(Ahmed, 2013b; Ahmed, 2014b; Song and Martin, 2017).  
It has also been suggested that anodal trans-spinal DC current stimulation (tsDCS) 
reduces spasticity by modulating the activity of the stretch reflex circuit (Winkler et al., 2010). The 
electrophysiological mechanisms through which tsDCS influences the stretch reflex synapse have 
been explained in the mid-20th century (Eccles et al., 1962). Working on cats, Eccles and his 
group determined that when tsDCS passed across the spinal cord, it generated changes in the 
membrane potential of the sensory afferent neurons, which in turn caused excitability changes in 
their associated motor neurons. Namely, anodal tsDCS depolarized the presynaptic terminals of the 
sensory afferents, decreasing their corresponding excitatory post-synaptic potential (EPSP). And 
cathodal tsDCS hyperpolarized the presynaptic terminals of the sensory afferents, increasing their 






junction of the frog, cathodal-induced hyperpolarization increased neurotransmitter release (Del 
Castillo and Katz, 1954). And in the skeletal muscles of rat, cathodal DC induced 
hyperpolarization of the presynaptic terminals, causing increased acetylcholine output. Anodal DC, 
however, caused the opposite effect (Hubbard and Willis, 1962a). Recent animal studies have 
confirmed these modulatory effects of DC stimulation. For example, intraspinal cathodal DC 
stimuli, applied locally at the dorsal horn or within the hindlimb motor nuclei, reduced afferent and 
motor neuron activity (Bolzoni and Jankowska, 2015). In other experiments, anodal tsDCS 
reduced the amplitude of synaptically mediated responses, and cathodal current caused them to 
increase (Ahmed, 2014b). Additionally, motor neurons showed decreased responses to anodal and 
increased responses to cathodal tsDCS (Ahmed, 2016; Song and Martin, 2017). In humans, anodal 
tsDCS was found to decrease the activity of ascending nociceptive tracts within the spinal cord, 
reducing pain conduction signals (Truini et al., 2011). It also decreased the amplitude of the 
cervico-medullary somatosensory potentials of the posterior tibial nerve; a reduction that continued 
for 20 minutes after stimulation stopped (Cogiamanian et al., 2008). These encouraging findings 
prompted this current study, which aims to test the potential noninvasive therapeutic potential of 
tsDCS in treating muscle tone abnormalities in the SCI-mouse model. 
Direct Current Stimulation Circuit 
Two known neuronal types contribute to abnormal muscle tone and spasticity: the alpha 
motor neurons (Hiersemenzel et al., 2000; Li et al., 2004) and the spinal interneurons (Kitzman, 
2006; Mailis and Ashby, 1990). Ahmed, (2014a) explained a procedure designed to target the 
hyperactivity of both types of neurons, utilizing two different loops in one DC circuit setup (figure 
1-1a). First, by targeting the DC flow between the spinal cord (a1 branch) and the sciatic nerve (c2 






Second, by targeting the DC flow between the spinal cord (a1) and the abdominal skin (c1), the 
excitability of the interneurons in the spinal cord was also influenced. The author also explained 
that the a2-c2 loop was designed to provide a charge balance, and deliver relatively higher DC 
values to the spinal cord, and only sub-threshold DC values to the sciatic nerve. This loop was 
crucial to avoid the deleterious effects of monopolar stimulation. However, this circuit was 
designed for anesthetized mice to receive DC immediately post-SCI, through electrodes placed 
invasively (surgically) under the skin. This current study proposes a new noninvasive method of 
DC delivery in awake mice, utilizing over-skin electrodes. Prior studies that tested the effects of 
tsDCS on neuronal circuits in mice utilized anesthetized animals. And while these studies provided 
great deal of information about the effects of DC, trials on anesthetized animals carry less clinical 
potential. Therefore, in this current study, we utilize awake mice to eliminate the side effects of 






























Figure 1-1    DC stimulation circuits 
 
a, trans-spinal DC stimulation circuit was previously developed in our laboratory to modulate 
muscle tone in anesthetized mice using trans-spinal DC stimulation (Ahmed, 2014a; Ahmed, 
2016). The circuit permits DC current to pass un-attenuated to the spinal cord, and attenuated to 
the sciatic nerve. b, a modified rendition of the original circuit in (a), used with over-skin 
noninvasive tsDCS in awake animals, as a permanent component of the mouse holder (figure 2-2). 
This was accomplished by keeping the anode (a) conductor intact, and dividing the cathode into 
two branches: one branch (c1), connected directly to the abdominal electrode, second branch (c2), 
connected to the sciatic nerve electrode. DC in the c2 branch was attenuated by passing through a 
















Hypothesis and Aims 
This study hypothesizes that noninvasive tsDCS (delivered through over-skin 
electrodes) can be used to reduce abnormal muscle tone and stretch responses (spasticity) tested in 
the triceps surae muscle (TS), and will improve recovery of locomotion and skilled movement in 
mice after SCI. The aims of this study are as follows: 1- To test the immediate and short-term 
effects (60 minutes) of anodal and cathodal tsDCS on muscle tone, in awake mice with spasticity, 
following SCI. 2- To compare the effects of invasive (implanted electrodes) and noninvasive 
(over-skin) tsDCS on muscle tone in mice with spasticity, following SCI. 3- To test the long-term 
effects of repeated, longer-duration anodal and cathodal tsDCS on muscle tone in awake mice with 
spasticity, following SCI. For the latter aim, the mice will receive daily, 20-minute, sessions of 
tsDCS for 7 days, and will be followed for 30 days.  4- To test the modulatory effects of longer-
duration, anodal and cathodal tsDCS on the stretch reflex circuit (using the rate-dependent 
depression (RDD) of the Hoffman reflex) in lightly anesthetized mice with spasticity, following 
SCI. 5- To test long-term effects of repeated-sessions anodal and cathodal tsDCS on spasticity and 
recovery of skilled locomotion in animals with SCI. 6- To test the immediate and short-term 
effects of tsDCS on muscle tone after the injection of the following drugs: Neurontin (gabapentin), 
morphine, and Dizocilpine (MK-801).  
Considering the strong evidence obtained from the preliminary experiments on 
anesthetized mice in our laboratory (Ahmed, 2014a; Ahmed, 2014b), it can be expected that the 
tsDCS modulatory effects on spinal cord activity can have a long-term effect, and maybe used to 
control muscle tone abnormalities in the SCI mouse model. Controlling muscle tone abnormalities 






These experiments will also help investigate the possible interactions and combined effects of 
























Chapter 2  – Methods and Material 
Animals 
Adult female CD-1 mice (n = 90, weight 27-37 g) were used for all experiments (table 
2-1). In this study, “sham” refers to mice that had received SCI, went through the protocol steps of 
the experiment, but did not receive tsDCS treatment. “Control” or “healthy” refers to mice that did 
not receive SCI, went through the protocol steps of the experiment, and did not receive tsDCS.  
In the pharmacologic studies, “experimental” refers to animals that received the drug 
being tested with tsDCS, while “control” refers to mice that received the drug, but no tsDCS.  
“Anodal group” identifies mice that received anodal tsDCS. In this group, the anodal 
electrode was positioned over the SCI site, and the current passed from the spinal cord to the 
sciatic nerve. “Cathodal group” identifies mice that received cathodal tsDCS. In this group, the 
cathodal electrode was positioned over the SCI site, and current passed from the sciatic nerve to 
the spinal cord. Both the anodal and cathodal groups are called the treatment groups. All study 
protocols were approved by the College of Staten Island’s Institutional Animal Care and Use 
Committee.  
For each stretch parameter tested using the apparatus, two sets of data were collected: a 
set collected while the animal was awake, and another set collected while the animal was under 
full isoflurane anesthesia. The data collected while the animal was anesthetized represented the 
passive resistive forces of muscle and connective tissue. To isolate the neuronal component of the 
stretch resistance from that caused by passive tissue, the value of the tested parameter collected 
during anesthesia was deducted from that collected while the animal was awake. This method 






Charles River Laboratories (USA) supplied the Breeder CD-1 mice. The College of 
Staten Island vivarium conducted the pairing and breeding process. All animals were placed in 
polycarbonate ‘Shoebox’ cages, and housed in a standard facility, where they were kept at 12 h 
light/dark cycle, and room temperature set to 70 °F and humidity averaged 30-70%. Each cage 
measured 7.25″ W × 11.5″ D × 5″. The animals were housed 3-5 per cage before the beginning of 
the study, then individually immediately after they received the spinal cord injuries. No 
environmental enrichments, such running wheels or toys were supplied in the cages. Cage 
maintenance included cleaning twice a week, and daily checks for food, water and wellness. Cage 
bedding was supplied by Andersons Bed-o’Cobs (USA). Mice had ad libitum access to filtered 

























Study Type Number of Animals 
Long-term effect of tsDCS 49 
Immediate effect of tsDCS 16 
Effect of tsDCS using implanted electrodes 4 
Morphine and effect of tsDCS 6 
MK-801 and effect of tsDCS 8 
Gabapentin and effect of tsDCS 7 
 
 
Table 2-1     The number of animals assigned to each experiment 
   













Spinal Cord Contusion Injury 
A ketamine/xylazine cocktail (90/10 mg/kg, i.p.) was used to deeply anaesthetize the mice. 
A laminectomy at thoracic (T) 10 vertebra was conducted to expose T13 spinal segment. The IH 
Spinal Cord Impactor (Precision Systems & Instrumentation, IH-0400; VA, USA) was used to 
standardize the contusion SCI force for all mice. The impactor was fully computerized once the 
desired contusion force level was selected using the system’s software. Impact force level was 
selected at 60 kdyn. This impact force level was determined based on data collected from a 
preliminary SCI contusion study using the impactor. The aim of the preliminary study was to 
determine the most ideal SCI contusion force needed to produce spastic mice. This was 
accomplished by creating contusion injuries in mice utilizing progressive impact forces. Mice 
impacted at 60 kdyn produced ideal spastic behavior, approximately 2-3 weeks post-injury (the 
number of animals used in the preliminary study is not included in table 2-1). All contusion 
impacts were conducted using the standard mouse tip (diameter = 1.3mm) at T13 spinal cord level, 
which was exposed by the laminectomy. Overlying muscles and skin were sutured after the 
contusion procedure. Next, the surgical site was covered with a layer of gentamicin sulfate 
ointment to prevent infection. The mouse then received a number and was placed on a warm pad 













A computer controlled stretch device was assembled from a stepper motor (ARCUS 
Technology INC, DMX-UMD-23, CA USA), a foot presser mounted on a force-displacement 
transducer (GRASS Technologies/NATUS, FT03, CA USA) connected to a bridge amplifier (Kent 
Scientific Corporation, Torrington, CT) (figure 2-1a, left), and a mouse holder (figure 2-2). The 
foot presser (figure 2-1a, right) was manufactured in our laboratory using 4.5 cm, number 8 
threaded rod, screwed at one end into a rigid 0.5x1.5 poly (vinyl chloride) (PVC) pad. The PVC 
pad was then heat-molded into a U-shaped plate to accommodate the flat surface of a mouse’s hind 
foot. The other end of the rod was screwed into the receiving inlet of the force-displacement 
transducer. The transducer was permanently fixed to a linear rail-guided carriage (ZNT Automatic 
Technology Co, SGB15NUU; Zhejiang, China). The rotational movement of the stepper motor is 
converted into linear displacement at the carriage using a set of jointed flat-aluminum rods.  
Two computer software programs were utilized to control the stepper motor and 
perform the online (during) stretch and electromyogram (EMG) recordings: The first, a stepper 
motor control software (ARCUS Technology INC, DMX-UMD GUI, CA USA) was re-written to 
permit the execution of three consecutive timed stretches, separated by two 10-second recovery 
intervals. The stepper motor was programed to provide three different stretch speeds: 18,180, and 
1800˚/s, which correspond to 3, 30, and 300 RPM, respectively. The second, LabChart-7 bundled 
with PowerLab data acquisition system software (ADInstruments, Colorado Springs, CO) was 
used for gathering and analyzing of the data. 
The following stretch parameters were collected: Active resistance peak amplitude, 
active slope, EMG area, and EMG amplitude. Active peak resistance is calculated as the height of 






derivative of the rising phase of the muscle resistance in response to stretching. EMG amplitude is 
calculated as the height of the EMG trace relative to baseline. EMG area is calculated as the area 

































Figure 2-1    Set up and procedure for testing spasticity in mice 
 
a, the stretch apparatus, constructed from stepper motor, movement arm, force-displacement 
transducer, and mouse holder. The system was controlled by computer software. Right image 
shows the positioned hindlimb mounted on the mouse holder, being tested for spasticity. b, Top: 
examples of muscle resistance traces recorded at three speeds: Speed 1 = 18 °/s; Speed 2 = 180 °/s; 
Speed 3 = 1800 °/s; the bottom two traces show raw (blue) and root squared (green) EMG. Left 
recordings are taken during awake condition, and right recordings are taken while the animal was 
fully anesthetized with isoflurane. * denotes EMG traces presence during deep anesthesia. c, Left: 
graph depicts the measured rising slope and peak force. Right: overlaid traces recorded during 



















The mouse restraining system, fabricated in our laboratory (figure 2-2), is made of three 
components: 1- A clear Plexiglas acrylic tube that served as the mouse holding chamber. 2- An 
internal adjustable support system made of a clear acrylic concave stabilization plate. The location 
of the plate could be adjusted along the length of the chamber linearly via a handle that protruded 
through a cutout made into the entire length of the tube. The concave surface of the plate was 
designed to contour to the back of the animal, securing it dorsally, and could be adjusted externally 
to different mouse sizes. 3- Four over-skin stimulating electrodes. Each electrode was made of 
wick-covered 1x1.5 cm stainless-steel plate. One of the electrodes was permanently fixed to the 
floor of the holding chamber, serving as the abdominal conductor. The second electrode was 
permanently fixed to the middle of the stabilization plate, serving as the dorsal conductor. This 
electrode could be aligned with the desired stimulation site on the spinal cord by moving the 
handle. The remaining two electrodes could be adjusted linearly by sliding into cutouts on the long 
sides of the stabilization plate, serving as the left and right sciatic nerve conductors. The design of 
the sciatic nerve electrodes enabled the positioning of the electrode directly over the sciatic nerve 
location on the skin. All electrodes had external connectors through the acrylic surface of the 
mouse holder to the current source. Clear acrylic was chosen to permit continuous visualization of 
the animal, and ease of cleaning. The abdominal surface of the holding chamber contained two 
openings, one for each of the animal’s hindlimbs. Each opening equipped with knee stabilizer pad 
to ensure full knee extension during testing. A third smaller opening on the abdominal surface of 
the holding chamber served as an injection access point for intraperitoneal (i.p.) drug 
administration. Before testing, a cap with an opening in the center was placed on the anterior end 






The detachable holding chamber was mounted on a support system made of an acrylic 
base and stand. The stand ended in an acrylic tubular clamp on which the holding chamber was 
inserted. The tubular clamp permitted rotational adjustment of the animals paw under the foot 
presser, and the selection of either hindlimb to be tested. To limit the hindlimb movement to the 
ankle joint during stretching; another acrylic stand was created to secure the distal leg. The stand 
ended in an adjustable stainless steel ankle stabilizer clamp that could be moved in the x, y and z 
axes. This was necessary for proper alignment of the foot under the presser, and adjusting the hip 










































Figure 2-2    Assembled mouse holder 
 
Designed to permit concurrent stretch and EMG testing during tsDCS, the mouse holder consists 
of a chamber, internal adjustable support system, and stimulating electrodes. Mounted on an 
acrylic stand, the holder contains four internal over-skin electrodes with external connectors to a 
power source: one abdominal (not shown), one spinal, and two sciatic nerve electrodes. Left sciatic 























Direct Current Stimulation Circuit and Electrodes 
Circuit and power source 
The tsDCS protocols of this study required the modification of a trans-spinal circuit that 
was originally designed in our laboratory to be used with anesthetized animals (Ahmed, 2014a). 
The original circuit was modified to pass DC to the spinal cord, and the sciatic nerve of the most 
affected limb, noninvasively, using over-skin electrodes. To prevent damage to the sciatic nerve, 
the current passing into the sciatic nerve electrode was attenuated. As shown in figure 1-1b, this 
was accomplished by keeping the anode (a) conductor intact, and dividing the cathode into two 
branches: the first branch (c1), connected directly to the abdominal electrode, carried un-attenuated 
current. The second branch (c2) was passed through a 300 KΩ resistor to attenuate current to the 
sciatic nerve. The same circuit was used for the two different protocols of tsDCS utilized in our 
experiments: Over-skin, and Implanted-electrodes. As a current supplier, a GRASS stimulator with 
a dedicated DC unit was used (GRASS Technologies/NATUS, S88, CA USA) (Ahmed, 2016). By 
switching the polarity of the current source, the circuit design permitted instant reversal of the 
current direction from anodal to cathodal, and vice versa. The circuit design was effective in 
attenuating sciatic nerve current: For each 1.5 mA passing through the spinal-abdominal 
electrodes, there was only 300 μA passing through the sciatic nerve circuit. Monitoring of current 
parameters and the verification of DC attenuation was performed in the beginning, during, and at 
the end of each experiment using a bench-top digital multi-meter (Agilent/Keysight Technologies, 









Over-skin mouse-holder electrodes 
Four mouse-holder electrodes designed for over-skin tsDCS were fabricated to permit 
concurrent over-skin tsDCS while testing the animal by the stretch apparatus (figure 2-1). The first 
electrode was permanently fixed to the middle of the stabilization plate, serving as the dorsal 
conductor, and connected to the anode (a). The second electrode was permanently fixed to the 
floor of the holding chamber, serving as the abdominal conductor, and connected to the (c1) 
branch. The remaining two were the sciatic nerve stimulating electrodes. Depending on which 
sciatic nerve was being stimulated, the corresponding electrode would be connected to the (c2) 
branch. To protect the sciatic nerve, current passing into the c2 branch was attenuated using a split 
current circuit (figure 1-1b). Each electrode was made of wick-covered 1x1.5 cm stainless-steel 
plate.  
Implantable electrodes system 
To provide under-skin trans-spinal DCS in awake animals, an implantable electrode 
system was fabricated according to (Ahmed, 2016). The system is made of spinal, abdominal and 
cuff electrodes. 
Spinal and abdominal electrodes 
Each electrode was fabricated using a stainless-steel plate (1.5 mm wide, 3 mm long, 50 
μm thick), placed in between soft cotton‐wick fabric (0.5 mm thick) and silicone rubber (178 μm 
thick) (Ahmed, 2016). Silicone adhesive was used to fuse all three layers. The electrode was, then, 
left to dry in room temperature overnight. Both spinal and abdominal electrodes were identical and 






soaked in sterile 0.9% saline solution for 3 hours before implanted. The spinal electrode was 
placed over the spinal column between T13‐L6 vertebrae. The abdominal electrode was placed 
between the skin and the abdominal wall.  
Cuff electrode 
The cuff electrode was fabricated according to Ahmed, 2016. A class of silicone tubing 
suitable for surgical implanting was used (2‐mm outer diameter (OD), 3 mm long, 1.5‐mm inner 
diameter (ID); AlliedSil) (figure 2-3). The conductors were made of stainless-steel wire (280‐μm 
overall diameter, 10 strands, 45‐Ω/foot impedance, nylon insulation material; Cooner Wire) 
(Ahmed, 2016). This wire was chosen due to the high degree of flexibility needed for implantation. 
In order to pass the wires into the silicone tubing, the hub of a 27‐gauge needle was snipped and its 
shaft was passed through the silicone tubing. Then the stainless-steel wires were passed through 
shaft’s lumen (Ahmed, 2016; Akay, 2014). A soldering iron was used to melt and remove the 
insulation from the portion of the wire that would act as the conductor within the silicone tube. The 
ends of the wires were then tied to prevent slipping from the silicone tubing. The distance between 
the two sciatic nerve conductors within the cuff was fixed at 2 mm for all electrodes. A (6 cm), 
number 6–0, silk suture was tethered between the two wires through the silicone tube to secure it 
during implanting. To prevent electrical current conduction in the tissue that surrounds the cuff, 
the silicone tubing, wire knots, and suture, were covered with silicone adhesive. To prevent 
tangling of the remaining wires during animal movement, they were clamped using a thinner 
silicone tubing (51‐μm inner diameter, 5‐mm long) (Ahmed, 2016). Silicone adhesive was then 
used to fill the thin tube. Next, a cut was made along one side of the 4mm length of the silicone 






loose end of each wire was then connected to a mini connector. The connectors from the nerve 
cuff, the spinal and abdominal electrodes were bonded together using super glue. 
Implanting the cuff electrode system 
 The electrode system was then sterilized with 100% alcohol in preparation for 
implantation. To induce deep anesthesia, the animals were injected with a ketamine-xylazine 
cocktail (90% ketamine/10% xylazine, mg/kg, i.p). Deep anesthesia was verified when the animal 
stopped exhibiting withdrawal reflex response to hind foot stimulations, using forceps (Ahmed, 
2016). They were then shaved on the thoracic back, and the most visually spastic hindlimb. Next, 
the area was disinfected with betadine before surgery started. Two incisions were made to the skin 
of the thoracic back, and the skin of the most spastic hindlimb, overlaying the sciatic nerve. To 
implant the electrode system, the spinal electrode was sutured with the silicone rubber side up, and 
the fabric side down, in complete contact with the spinal cord, covering vertebral levels between 
T13 to L6. The abdominal electrode was laid with the silicone side against the lateral abdominal 
wall and the fabric side pointing towards the deep side of the skin.  
To attach the cuff electrode around the sciatic nerve, the sciatic nerve had to be 
exposed. This was done by dissecting the fascia between two muscles, the gluteus superficialis and 
biceps femoris. Once the muscles were separated, the sciatic nerve was freed from the surrounding 
connective tissue, and meticulously placed within the cuff (Ahmed, 2016). The cuff was, then, 
anchored to the gluteus superficialis muscle with one suture. To enhance the conductivity of the 
electrodes, sterile saline was used to moisten the tsDCS electrodes and completely fill the silicone 
tubing of the cuff. The surgical site was, then, covered with a layer of gentamicin sulfate ointment 
to prevent infection. The mouse then received a number and was placed on a heated tray (30 °C) 































Figure 2-3     Implantable electrode system 
 
a, the cuff electrode. b, left, the assembled implantable electrode system. Right, the animal moved 


























The Effects of Direct Current Stimulation on Spasticity in Combination with 
Pharmacological Agents  
Drug administration and protocols 
Each animal was weighed then mounted to the stretch apparatus, and a baseline 
recording was taken before drug administration. Drug dose was calculated based on body weight. 
All control animals of the drug studies received sham tsDCS by going through the exact process as 
the experimental animals without turning the current on.  
Isoflurane 
In order to separate the passive and neuronal components of stretch resistance, a set of 
data were collected while the animals were fully anesthetized. Isoflurane was chosen as the drug of 
choice for this step due to its fast elimination half-time. Isoflurane was administered to all animals 
at the end of each study via inhalation: A Q-tip was soaked in isoflurane until saturated, then 
brought in contact with the animal’s nose through an opening in the cap of the mouse holding 
chamber.  
Morphine 
 Morphine was dissolved in a sterile 0.9% saline solution, and administered in 30 
mg/kg, i.p. Two groups of uninjured mice were used for this study: 1) an experimental group 
(n=5), received anodal tsDCS, 2) a non-stimulated, control group (n=2). All animals were tested 
using the stretch apparatus for stretch resistance and corresponding EMG activity. The study 
protocol proceeded as follows: a baseline recording was taken, followed by morphine injection. 






Subsequently, to test responses to morphine rigidity during tsDCS, more recordings were taken 
immediately, 10 minutes, and 20 minutes after anodal tsDCS treatment started. 
Gabapentin  
Gabapentin (GABAp) was dissolved in a sterile 0.9% saline solution, and administered 
in 50 mg/kg, i.p. Two groups of mice with SCI were used for this study: 1) an experimental group 
(n=6) received anodal tsDCS, 2) a non-stimulated, control group (n=2). All animals were tested 
using the stretch apparatus for stretch resistance and corresponding EMG activity. Initially, a 
baseline recording was taken before GABAp injection. Then another recording was taken 30 
minutes after injection to test GABAp effect before tsDCS. Subsequently, to test responses to 
spasticity during tsDCS, more recordings were taken as follows: during anodal tsDCS, when the 
anodal current was turned off, during cathodal tsDCS, and when the cathodal current was turned 
off. Similarly, the same animal group was used to test the effect of a longer duration (20 minute) of 
anodal tsDCS treatment after GABAp injection. 
MK-801 
MK-801 was dissolved in a sterile 0.9% saline solution, and administered in 0.6 mg/kg, 
i.p. Two groups of mice with SCI were used for this study: 1) an experimental group (n=6), 
received anodal tsDCS, 2) a non-stimulated, control group (n=2). All animals were tested using the 
stretch apparatus for stretch resistance and corresponding EMG activity. Initially, a baseline 
recording was taken before MK-801injection. Then another recording was taken 55 minutes after 
injection to test MK-801effect before tsDCS. Subsequently, to test responses to spasticity during 
tsDCS, more recordings were taken as follows: during anodal tsDCS, when the anodal current was 






During and Short-Term Effects of Direct Current Stimulation 
To examine changes in spasticity in response to the immediate (during) and short-
duration tsDCS, SCI-female CD-1 mice were randomly selected to one of three groups: anodal 
(n=5), cathodal (n=5), or sham (n=6). The animals of the anodal and cathodal groups received one 
tsDCS treatment according to their group assignment for 20 minutes, at 1.5 mA. Animals of the 
sham group went through the same procedure as the other two groups, but received no tsDCS.  
Prior to testing and tsDCS, the skin areas covering the SCI injury site and the sciatic nerve of the 
most affected hindlimb were shaved. The shaved skin of the animal and the mouse holder 
electrodes were wetted with 3% NaCl solution to promote DC conduction. Then the animal was 
placed in the mouse holder, mounted on the stretch apparatus, and received a baseline recording 
before tsDCS started. Once a baseline recording was taken, the tsDCS, whether cathodal or anodal, 
was turned on and went uninterrupted for the entire treatment period of 20 minutes. More 
recordings were taken while the animal was receiving tsDCS (during), immediately after the 
current was terminated, and every 10 minutes for 60 minutes.  
Procedure of Repeated-Session (Long-Term) Direct Current Stimulation  
This study was conducted to investigate the long-term effects of repeated-sessions 
anodal and cathodal tsDCS on spasticity in animals with SCI. Female CD-1 mice with SCI were 
randomly selected to one of three treatment groups: anodal (n=16), cathodal (n=15), or sham 
(n=10). A fourth group (n=8), did not receive SCI, served as the non-injured control (healthy 
group). All animals received initial baseline testing, which included the following: peak resistances 
at 3 different stretch speeds, EMG activity, skilled locomotion testing, and locomotion recovery 
testing. A total of nine mouse holders were fabricated to provide tsDCS to multiple animals, 






study. One shave on the first day of the long-term study was sufficient for the entire week of 
tsDCS sessions. The shaved skin of the animal and the mouse holder electrodes were wetted with 
3% NaCl before each session. Animals of the anodal and cathodal groups received daily 20-minute 
tsDCS (1.5 mA) treatments for 7 days, according to their group assignment. Animals of the sham 
and control groups went through the same procedure as the treatment groups, but received no 
tsDCS intervention. Using the same baseline testing parameters, the animals were reevaluated 
immediately after the conclusion of the 7-day tsDCS treatment period, then at two weeks, and four 
weeks post-treatment. Additionally, following the last evaluation, the animals were tested for rate-
dependent depression of the Hoffman reflex. 
Locomotion Recovery Testing 
The DigiGait system (Mouse Specifics Inc., Framingham, MA) was used to quantify 
locomotor recovery following SCI and tsDCS treatment (figure 3-4a). The system films the ventral 
aspect of the animals through a transparent treadmill belt. The system includes software that 
employs algorithms to quantify the characteristics of animal locomotion. All groups were tested 
four times by the DigiGait system: before, immediately after, two, and three weeks after tsDCS 
interventions. The control group was tested twice, two weeks apart. During testing, a minimum of 
20 steps were collected at two speeds: 10 cm/s, and 20 cm/s. Three parameters measured during the 
stance phase of the mouse locomotion were chosen. These parameters are sensitive to changes in 
locomotion as a response to changes in muscle tone after tsDCS. These parameters are as follows: 
the peak paw area, rising slope and falling slope. Peak paw area is calculated as the maximum 
contact area of the foot of the mouse with the DigiGait treadmill belt. This rising slope is an 
indicator of the speed of locomotion during the first half of the stance phase of the mouse 






mouse is in contact with the treadmill belt. The falling slope is an indicator of the speed of 
locomotion during the second half of the stance phase of the mouse locomotion cycle.  
Skilled-Locomotion Recovery Testing 
The ladder-wheel (figure 3-5a) was assembled in our laboratory from a stepper motor, a 
driver, and a controller (ARCUS Technology INC, DMX-UMD-23, CA, USA). The speed and 
direction of the wheel is controlled by custom-written software. The wheel is made from Plexiglas 
to allow side visualization. Spaces between rungs were variable to prevent memorization.  A 
camera was placed under the animal to record foot faults. Animals were tested before stimulation 
started and once a week for three weeks after stimulation ended. 
Video analysis of the ladder-wheel task 
For each recorded session, a continuous 90 second video underwent a frame-by-frame 
analysis using a foot fault scoring system previously described by Metz and Whishaw (2009) (see, 
table 2-2). The score for each of the animal’s hindlimbs was calculated by multiplying the number 
of foot fault by its corresponding score for each criterion according to table 2-2 to get the 
















Table 2-2    Ladder wheel error scores 
 
Scoring system used to evaluate skilled walking using the ladder wheel apparatus (Metz and 
Whishaw, 2009).  
 
Foot Fault Score                                                   Description  
Total miss 0 Assigned when a limb completely misses a rung and a fall occurs. A fall 
is defined as a limb deeply falling in-between rungs with body posture 
and balance disturbed. 
Deep slip 1 Assigned when a limb is initially placed on a rung, then it slips off upon 
weight bearing and this causes a fall. 
Slight slip 2 The limb is placed on a rung and then slips off upon weight bearing. 
However, the slip does not result in a fall and the animal is able to 
maintain balance and a coordinated gait. 
Replacement 3 The limb is placed on another rung in the same step (score 3) and then 
slips and falls in-between rungs (score 1). For this a score of 1 is 
recorded. When a fall occurs, only the limb initiating the error is rated 
placed on a rung, but before it is weight bearing it is quickly lifted and 
placed on another rung. 
Correction 4 When a limb aims for one rung yet is placed on another rung without 
touching the original rung. Alternatively, if a limb is placed on a rung 
and is quickly repositioned while remaining on the same rung. 
Partial 
placement 
5 The limb is placed on a rung with either the wrist or digits of the 
forelimb, or with the heel or toes of the hindlimb. 
Correct 
placement 
6 The mid-portion of the palm of a limb is placed on a rung and can bear 






Rate-Dependent Depression of the Hoffman Reflex (RDD) 
Following the last evaluation, animals were anesthetized using mixture of ketamine and 
xylazine (90 mg/kg). The animals were shaved at the hindlimb and pelvic area. Two sets of 
recording electrodes were used to record EMG, and heart rate and breathing activity. Stimulation 
of the tibial nerve was achieved using concentric needle stimulating electrode (figure 3-6a, right). 
Following positioning the animal on the recording station, the heart (HR) and respiratory (RR) 
rates were monitored online. In deeply anesthetized animals, typically HR and RR were faster and 
RR was shallower. At that level of anesthesia, the reflexes were difficult to evoke and if evoked, 
the RDD was very high even in animals expressing severe spasticity. Therefore, in exploratory 
experiments, the procedure was standardized by monitoring the relationship between both HR and 
RR and the levels of awareness of the animal and RDD. For example, as animals awaken the HR 
first becomes regular at 2 Hz then becomes more irregular between 2 and 4 Hz, and RR becomes 
deeper and slower (figure 3-6b, c, and d). At the beginning of the irregular HR and deeper RR 
phase, the RDD protocol was started. It consists of five trains of 5 pulses. Frequencies of the trains 
were at 0.1, 0.5, 1, 2, and 5 Hz. The waiting intervals between the trains were 1-minute long. 
Testing was done on both hindlimbs. Stimulation intensity was gradually increased until the 
maximum H-wave relative to M-wave is seen, followed by the RDD protocol. Data was collected 
using the PowerLab system (ADInstruments, Colorado Springs, CO), recorded at sample rate of 10 
KHz, and filtered at low pass of 2 kHz and high pass of 100 Hz. The data were averaged using the 
root square mean function with a 1-ms window using a built-in function in the LabChart software 
(ADInstruments, Colorado Springs, CO). Peaks of the averaged H-wave were measured and 
percent of change was calculated relative to the baseline values. RDD was calculated as the 






the first pulse in a train divided by the amplitude of the H-wave induced by the first pulse, 




























Repeated measures ANOVA (RM ANOVA) was used to analyze the data for the 
following experiments: 1- the implanted system, 2- the during and short-term effects of tsDCS on 
muscle peak resistance, 3- the long-term effects of tsDCS, 4- the paw area responses to tsDCS, 5- 
the effect of tsDCS on the rising and falling slope in locomotion, 6- effects of tsDCS on RDD, 7- 
the effect of tsDCS on peak resistance with GABAp 7- The effect of tsDCS in MK-801-injected 
mice. All assumptions for the use of repeated-measures ANOVA were fulfilled. Holm–Sidak post-
hoc correction was used to test differences between speeds in the stretch responses, the skilled 
motion, the GABAp, the morphine and MK-801 experiments. Post-hoc analysis was used to 
analyze the difference between the Anode and cathode in tsDCS treated animals. Mixed factorial 
ANOVA was used to assess the difference in EMG amplitude. The two-tailed paired t-test was 
used to analyze the difference between the two evaluations of the control groups in the skilled 
locomotion study. Bonferroni test was used to analyze the control group evaluations. Mixed two 
way repeated measures ANOVA was used to analyze the main effects between groups for the 
skilled locomotion. Friedman RM ANOVA was used to analyze the tsDCS on morphine rigidity, 
and Chi square to assess the difference between speeds. SPSS software was used to perform all 












Data Collection and Blindness 
A total of six research assistants gathered and filed data and calculated the scores for 
each animal: four research assistants transferred the stretch apparatus data from the LabChart 
software to Excel sheets, and calculated the scores for each animal using embedded Excel sheets 
formulas. One research assistant analyzed the DigiGait (unskilled locomotion) and ladder wheel 
(skilled locomotion) videos. And another assistant ran the data into embedded excel sheet formula 
to calculate animal scores. All assistants were blinded to the study hypothesis. Root mean square 
(RMS) equations were embedded in LabChart with window of 0.5 ms to generate the RMS for 


















Chapter 3  – Results 
Immediate Effects of Direct Current Stimulation on Spasticity using Implanted Electrodes 
To investigate the immediate changes in spasticity as a result of tsDCS in mice with 
SCI, electrode systems were implanted in SCI animals (figure 2-3). After a recovery period of 48 
hours, the animals were placed in the mouse holder, and mounted on the stretch apparatus for 
testing. Recordings of the animal’s peak resistance and EMG were taken before and after tsDCS 
(1.5 mA). Stretch testing shows that spinal anodal tsDCS treatment for 20 minutes caused 
significant reduction of muscle peak resistance in all speeds (figure 3-1). The reduced peak 
resistance was evident during stimulation, and continued for 60 minutes after the current stopped. 
The third speed showed the most reduction of peak resistance. Contrarily, cathodal tsDCS caused 
significant increase in peak muscle resistance during stimulation compared to baseline, but not 
afterward. Sham treatment, on the other hand, showed no changes in muscle peak resistance in any 
of the speeds. These results indicate that anodal and cathodal tsDCS have opposite effects on 
spasticity: cathodal current increases stretch responses only while the current is applied, with no 
significant carryover effect after the current is terminated. However, anodal current decreases 
stretch responses significantly; a response that was maintained for at least a full hour after the 



































Figure 3-1     Implanted system to deliver anodal tsDCS 
 
Applying anodal tsDCS (n = 4) results in significant reduction in muscle peak resistance (RM 
ANOVA, for speed 1: F = 5.99, p < 0.001; for speed 2: F = 8.61, p < 0.001; for speed 3: F = 17.07, 



























Immediate Effects of Direct Current Stimulation on Spasticity using Over-Skin Electrodes 
Unlike the mice with implanted electrode systems, these animals received tsDCS via 
over-skin electrodes within the mouse holder to investigate immediate changes in spasticity as a 
result of tsDCS. In corroboration with the findings from the implanted electrode study (figure 3-1), 
over-skin tsDCS for 20 minutes caused significant reduction of muscle peak resistance in all 
speeds (figure 3-2a). The reduced peak resistance was evident during stimulation, and continued 
for the testing period of 60 minutes after the current stopped. The third speed showed the most 
reduction of peak resistance. Once more, cathodal tsDCS caused significant increase in peak 
muscle resistance during stimulation compared to baseline, but not afterward (figure 3-2b). Sham 
treatment, on the other hand, showed no changes in muscle peak resistance in any of the speeds 
(figure 3-2c). Comparable to the findings of the implanted electrodes study, these results confirm 
that anodal and cathodal tsDCS have opposite effects on spasticity responses. While increases in 
stretch responses following cathodal stimulation occur significantly during stimulation, they 
subside after termination of current. And anodal current, again, results in a significant reduction of 
stretch responses that persisted after termination of current. These findings indicate that the results 






















Figure 3-2     During and short-term effects of tsDCS on muscle peak resistance in animals 
with spasticity after SCI 
 
a, anodal tsDCS (n = 6) causes reduction of muscle peak resistance in all speeds, during and for 60 
min after application (RM ANOVA, for speed 1, F 3.57, p = 0.003, for speed 2, F = 3.96, p = 
0.002; for speed 3, F = 13.44, p < 0.001). *p < 0.01 compared to baseline, Holm-Sidak method. b, 
cathodal tsDCS (n = 5) causes significant increase in peak muscle resistance during stimulation 
(During) compared to baseline (BL), but not afterward (RM ANOVA, for speed 1, F = 3.98, p = 
0.002, for speed 2, F = 3.74, p = 0.002, for speed 3, F = 3.35, p = 0.005). *p < 0.05 compared to 
baseline, Holm-Sidak method. c, Sham treatment (n = 5) shows no changes in muscle peak 
resistance in all speeds (RM ANOVA, for speed 1, F = 1.0, p = 0.455; for speed 2, F = 0.83, p = 















Repeated Sessions of Direct Current Stimulation Produce Long-Term Effects on 
Spasticity 
This study was conducted to investigate the long-term effects of repeated-sessions 
tsDCS on spasticity in animals with SCI. The animals of this study were divided into 4 groups:  
1- Anodal tsDCS (n = 16); received 20-minute daily anodal tsDCS for 7 days. 
2- Cathodal tsDCS (n = 15); received 20-minute daily cathodal tsDCS for 7 days. 
3- Sham (n = 10), SCI mice, received 20-minute daily sham tsDCS for 7 days. 
4- Control (n = 8), uninjured, received 20-minute daily sham tsDCS for 7 days. 
The data of four parameters were collected: Active resistance peak, active slope, EMG 
area, and EMG amplitude. All four parameters were calculated by subtracting the raw amplitude 
value obtained while the animal was anesthetized with isoflurane from the raw amplitude value 
while the animal was awake. The differences in amplitude of active muscle resistance was assessed 
using mixed factorial ANOVA using time (4 levels: pre, E1, E2, and E3), and speed (3 levels: 
speeds 1, 2, and 3) as within subjects variables, and condition (three levels: anode, cathode, and 
sham) as between subjects variable. There is no significant interaction between the factor of 
condition and the factor of speed. The effect of different level of speed does not depend on what 
level of condition is present (F (6,114) = 0.4, p = 0.81). However, there is a significant interaction 
between condition and time of evaluation (F (6,114) = 2.36, p = 0.03). After adjustment for 
multiple comparison (Bonferroni), there is significant marginal mean difference between anode 
and cathode treated animals (p < 0.001), and between anode and sham treated animals (p < 0.001), 
but no significant difference between cathode and sham treated animals (p = 0.13) in E2, E3, and 
E4, but shows no significance difference between anode, cathode, and sham treated animals at E1 






After 7 days of 20-minute daily treatment with anodal tsDCS, SCI mice showed significant long-
term depression of peak muscle resistance, and significant reduction in rising slope (figure 3-3, a 
and b). These significant depressions were evident in all three stretch speeds. On the other hand, 
cathodal or sham treatments resulted in no significant difference. Additionally, anodal tsDCS 
resulted in a significant reduction in EMG amplitude and EMG area (figure 3-3, c and d), which 
was evident in all three stretch speeds. However, the cathodal or sham treatments results in no 
significant difference. These results indicate that repeated stimulations using anodal current have 









































Figure 3-3     Treatment with anodal tsDCS results in long-term depression of spasticity in 
mice with SCI 
a, animals treated with anodal tsDCS had significant reductions in the amplitude of active muscle 
resistance. The mean scores among the different levels of time within speed1 is statistically 
significant compared to pre-treatment score (E1, p < 0.001; E2, p = 0.003; E3, p = 0.002, Holm-
Sidak method). The mean scores among the different levels of time within speed 2 is statistically 
significant compared to pre-treatment score (E1, p < 0.001; E2, p = 0.038; E3, p = 0.027, Holm-
Sidak method). The mean scores among the different levels of time within speed 3 is statistically 
significant compared to pre-treatment score (E1, p < 0.001; E2, p = 0.004; E3, p = 0.046, Holm-
Sidak method). b, Anodal tsDCS results in significant reduction in rising slope. The difference in 
active slope was also assessed using mixed factorial ANOVA. The analysis shows significant 
interaction between time and treatments (F (2, 114) = 3.59, p = 0.03). There was no interaction 
between speed and treatments. Post-hoc analysis shows significant main difference between Anode 
and cathode treated animals (p = 0.015), and between anode and sham (p = 0.04) during E2, E3, 
and E4. There was no difference between sham and cathode treated animals (p = 0.829). c, Anodal 
tsDCS results in significant reduction in EMG area. d, Anodal tsDCS results in a significant 
reduction in EMG amplitude. Both EMG area and amplitude analysis show similar results: the 
difference in EMG amplitude was assessed using mixed factorial ANOVA. The analysis shows 
significant interaction between time and treatments (F4, 218) = 3.63, p = 0.007). There was no 
interaction between speed and treatments (F (4,218) = 0.61, p = 0.66) nor between speed, time, and 
treatments (F (8,218) = 0.19, p = 0.9). Post-hoc analysis shows significant difference between 
anode and cathode treated animals (p <0.001), and between anode and sham treated animals (p = 







The DigiGait system was used to quantify locomotor recovery following SCI and 
tsDCS treatment (figure 3-4). In general, there was significant correlation between peak area, 
rising, and falling slopes in all groups (Pearson product moment correlation, p < 0.05). This 
indicates that the three parameters are mechanistically and functionally linked. Anodal tsDCS 
treated animals show significant increase in paw area at all evaluations during slow speed (E1-E3) 
for the left hindlimb (LHL) and E1 and E2 only for the right hindlimb (RHL). Paw area is 
significantly increased in E1 during fast speed for the LHL, and for the RHL. Rising slope is 
significantly increased during slow speed in E1 and E2 for RHL, but not for LHL. Rising slope is 
significantly increased in E1 during fast speed for RHL only. Falling slope is significantly 
increased in E1 and E2 during slow speed for LHL, and for RHL. Falling slope is significantly 
increased in E1 during fast speed for RHL only (figure 3-4d). 
Control animals show no difference in the paw area, rising slope, or falling slope 
between the two evaluations of the two limbs (figure 3-4b). However, sham treated animals show 
significant decrease in evaluations (E1-E3) in paw area of the left hindlimb (LHL) during slow 
speed, but not for right hindlimb (RHL). Paw area is significantly decreased in all evaluations (E1-
E3) during fast speed for LHL, but not significant change for RHL. Rising slope is significantly 
decreased in E1 during slow speed for the LHL, but not for the RHL (figure 3-4c). Rising slope is 
not changed significantly during fast speed for both hindlimbs. Falling slope is not significantly 
decreased for both hindlimbs during the slow speed. Falling slope is significantly decreased in all 
evaluation during fast speed for the LHL, but not for RHL. 
The cathodal tsDCS treated animals show significant increase in paw area in E1 during 






paw area in all evaluations during fast speed. Rising slope is not changed during slow or fast 
speed. Falling slope is significantly increased in E1 and E 2 for the LHL for slow speed, and for E1 










































Figure 3-4    Repeated treatment with anodal tsDCS results in changes in spastic animals’ 
locomotion patterns 
a, schematic of the DigiGait system showing the general setup. Animal locomotion was tested at 
two speeds: 10 cm/s, and 20 cm/s. A typical recording is shown on the top right. Three parameters 
were taken for analysis: rising slope, peak paw area, and falling slope. The bottom figure shows 
recordings of stance phases from a representative animal from each group. b, control healthy 
animals were evaluated twice separated by 2 weeks. Gray bar for left hindlimb (LHL); blue bar for 
right hindlimb (RHL); E1: evaluation 1; E2: evaluation 2. Control animals show no difference in 
the paw area, rising slope, or falling slope between the two evaluations of the two limbs (p >0.05; 
two-tailed paired t-test). c, sham treated animals show significant decrease in evaluations (E1-E3) 
in paw area of the LHL during slow speed (RM ANOVA, F = 4.75, p = 0.009), but not for RHL. 
Paw area is significantly decreased in all evaluations (E1-E3) during fast speed for LHL (RM 
ANOVA, F = 5.54, p = 0.005), but not significant change for RHL. Rising slope is significantly 
decreased in E1 during slow speed for the LHL (RM ANOVA, F = 3.20, p = 0.039), but not for the 
RHL. Rising slope is not changed significantly during fast speed for both hindlimbs. Falling slope 
is not significantly decreased for both hindlimbs during the slow speed. Falling slope is 
significantly decreased in all evaluation during fast speed for the LHL (RM ANOVA, F = 4.47, p = 
0.012), but not for RHL. *p < 0.05, Holm-Sidak method. d, anodal tsDCS treated animals show 
significant increase in paw area at all evaluations during slow speed (E1-E3) for LHL and E1 and 
E2 only for RHL (RM ANOVA, for LHL: F = 12.70, p < 0.001; for RHL: F = 17.32, p < 0.001). 
Paw area is significantly increased in E1 during fast speed for the LHL (RM ANOVA, F = 7.04, p 
< 0.001), and for the RHL (RM ANOVA, F = 13.32, p < 0.001). Rising slope is significantly 






LHL. Rising slope is significantly increased in E1 during fast speed for RHL only (RM ANOVA, 
F = 4.19, p = 0.011). Falling slope is significantly increased in E1 and E2 during slow speed for 
LHL (RM ANOVA, F = 10.03, p < 0.001), and for RHL (RM ANOVA, F = 13.48, p < 0.001). 
Falling slope is significantly increased in E1 during fast speed for RHL only (RM ANOVA, F = 
9.06, p < 0.001). *p < 0.05, Holm-Sidak method. e, cathodal tsDCS treated animals show 
significant increase in paw area in E1 during slow speed compared to baseline (RM ANOVA, for 
LHL: F = 7.92, p < 0.001; for RHL: F = 8.46, p < 0.001) but not in E2 or E3. No significant 
change is seen in paw area in all evaluations during fast speed. Rising slope is not changed during 
slow or fast speed. Falling slope is significantly increased in E1 and E 2 for the LHL (RM 
ANOVA, for slow speed: F = 6.72, p < 0.001), and for E1 only for the RHL (RM ANOVA, for 
slow speed: F = 3.47, p = 0.025). *p < 0.05, Holm-Sidak method. There is no significant change in 

















Anodal Treatment Enhances Recovery of Motor Control of Skilled Locomotion 
The effect of the repeated tsDCS on skilled locomotion was investigated using a 
computer controlled ladder wheel (Figure 3-5A). There was a significant difference across the four 
time points in the anode treated group (F = 6.49, p = 0.002). The RHL anode treated group showed 
statistically significant higher mean score in E2 compared to E1 (p = 0.001, Bonferroni). The LHL 
of the anode treated group showed statistically significant higher score in E2 and E4 compared to 
E1 (p < 0.01, Bonferroni) (Figure 3-5B). No other group showed significant difference across the 
four time points (p > 0.05, Bonferroni).   
Next, the percent change (from pre-evaluation) between groups (Figure 3-5C) was 
compared. Mixed two way repeated measures ANOVA showed significant main effects among the 
groups (F = 5.97, p = 0.016). Anode group showed significantly higher percent change in scores 
compared to cathode group (p = 0.027, Bonferroni), and healthy group (p = 0.048, Bonferroni). 
Anode group showed higher percent change than sham group, however, not statistically significant 
(p > 0.05). There were no significant differences among other the groups (p > 0.05). 
Overall, these findings reveal enhanced recovery of motor control of skilled locomotion in 
anode-treated animals. Two major findings can be deduced from the above results: 1) since the 
healthy group did not show changes in the skilled locomotion scores, this indicates no motor 
learning is possible using our motorized ladder-wheel system. And that the motorized ladder-wheel 
test is probing motor control and not motor learning. 2) By reducing spasticity, anodal treatment 


















Figure 3-5    Enhancement of skilled locomotion following repeated anodal tsDCS treatment 
 
a, left: an image of the ladder-wheel; right: consecutive frames showing a total miss occurred by 
the hindlimb. b, summary plots showing mean score of skilled locomotion. Sham, SCI group that 
was sham treated; healthy group, no injury/no treatment; anode, SCI group that was treated 
repeatedly for 7 days; cathode, SCI group that was treated for 7 days. c, summary plots showing 
percent change (of pre-treatment evaluation or first evaluation in healthy controls). Data shows as 




















Rate-Dependent Depression of the Hoffman Reflex (RDD) 
Mixed two way repeated measures ANOVA was conducted to assess the changes in 
RDD. The treatment condition (independent factor, 4 levels: control, sham, anode, and cathode) 
shows significant difference in the main effect among the different levels of treatment (F = 3.0, p = 
0.038). There is also significant main effect of frequency (within subjects repeated factor, 5 levels: 
0.1, .5, 1, 2, and 5 Hz) (F = 13.8, p < 0.001). There is not a statistically significant interaction 
between frequency and treatment condition (F = 1.35, p = 0.192). The effect of different levels of 
treatment does not depend on what level of frequency is present.  
Multiple comparison test (Tukey) was applied to isolate which group (s) differ from the 
others. As shown in figure 3-6, within control, the mean scores of RDD at frequencies 1, 2, and 5 
Hz are significantly higher compared to RDD at 0.1 Hz (5 vs. 1 Hz, p <0.001; 4 vs. 1Hz, p = 
0.006; 3 vs.1, p = 0.024). Within sham, the mean scores of RDD at all frequencies are not 
significant compared to RDD at 0.1 Hz (p > 0.05). Within anode, the mean scores of RDD at 
frequencies 2, and 5 Hz are significantly higher compared to RDD at 0.1 Hz (5 vs. 1 Hz, p <0.001; 
4 vs. 1Hz, p <0.001). Within cathode, the mean scores of RDD at 1 Hz is significantly higher 
compared to RDD at 0.1 Hz (p = 0.017).  
Between groups comparison (Tukey) shows significant differences of RDD scores at 
5Hz. RDD score at 5 Hz is significantly higher in the anode group compared to both sham and 
cathode groups (p < 0.05). The control group shows significantly higher RDD at 5 Hz compared to 
cathode group (p = 0.016). Overall, these findings provide physiological mechanism that 


















Figure 3-6    Rate-dependent depression of Hoffman reflex after repeated sessions of tsDCS 
stimulation 
 
a, left photograph: visible attributes of spasticity in animals with SCI; right photograph showing 
the recording setup. SE, stimulating electrode; RE recording electrode. The two recording traces 
on the right in (a) are the raw trace (top), and the root-mean square calculated trace (bottom). b, the 
respiratory rate (RR) during deep anesthesia (blue), and 45 min after anesthetic injection (orange). 
c, Top: heart rate (HR) during deep anesthesia (blue), and after 45 min of injection (orange); 
bottom: the full recording, with breaks, showing the HR at which RDD testing took place. d, 
showing changes when RDD was tested during deep anesthesia versus during light anesthesia. e, 
representative recordings from different groups. f, left: summary blots showing the average RDD 
in different groups. RDD is significantly higher in control group (n = 12) for rate 1-5 Hz compared 
to rate 0.1 Hz (RM ANOVA, F = 8.815, p < 0.001). RDD in sham group is significantly higher at 
rates 2 and 5 compared to 0.1 Hz (RM ANOVA, F = 3.725, DF = 16, p = 0.009). RDD in anodal 
tsDCS group is significantly higher at rates 1-5 Hz compared to 0.1 Hz (RM ANOVA, F = 8.598, 
FD = 16, p < 0.001). RDD in cathodal tsDCS group is significantly higher at rates 1 and 5 Hz only 
(RM ANOVA on Ranks, Chi-square= 16.933, n = 12, p = 0.002. *significant from RDD at 0.1Hz 
in the same group (Holm-Sidak method; **significant from respective RDD in sham group (t-test). 








Effect of Direct Current Stimulation after Gabapentin Injection 
Gabapentin (GABAp) is a drug with many pharmacologically therapeutic effects: it has 
been found to treat epilepsy and reduce spasticity after SCI through multiple cellular mechanisms. 
Although not a GABA receptor agonist, it has been suggested that GABAp works by increasing 
GABA synthesis and inhibiting glutamatergic transmission (Kitzman et al., 2007).  
This study aimed to investigate tsDCS effect on GABAp’s ability to reduce stretch peak resistance 
in mice with SCI, during and after 20-minutes of anodal tsDCS. Two groups of mice with SCI 
were used for this study: 1) an experimental group (n=6), received anodal tsDCS, 2) a non-
stimulated, control group (n=2). Data show that there was significant decease after 30 min of 
GABAp injection and further significant decrease during anodal tsDCS (figure 3-7b). In the same 
group of animals, 20 min of anodal tsDCS results in further significant depression of peak muscle 
resistance for speed 1, but not for the other two speeds (figure 3-7c). There was a steady reduction 
of peak muscle resistance during sham treatment in the control group (figure 3-7d). The data 
indicate that anodal tsDCS adds further depression to peak resistance in addition to the depression 























Figure 3-7    Anodal tsDCS adds further depression to peak muscle resistance following the 
depression induced by injecting GABAp 
 
a, examples of traces of muscle force recording and their respective EMG. b, Summary plot shows 
significant decrease of peak resistance after 30 min of gabapentin injection (n = 6; RM ANOVA, 
for speed 1, F =  14.66, p < 0.001; for speed 2, F = 11.14, p < 0.001; for speed 3, F = 16.43, p < 
0.001), and further significant decrease during anodal tsDCS (RM ANOVA, for speed 1, F =  
8.96, p < 0.001; for speed 2, F = 11.68, p < 0.001; for speed 3, F =  18.20, p < 0.001). *p < 0.001 
Holm-Sidak method. c, In the same group of animals, 20 min of anodal tsDCS results in 
significant depression of peak muscle resistance for speed 1 but not the other two speeds (RM 
ANOVA for speed 1, F = 8.63, p = 0.007). *p < 0.01 Holm-Sidak method. d, control group (n =2) 















Effects of Direct Current Stimulation after Morphine Injection 
Morphine injection has long been associated with catatonic rigidity (Widdowson et al., 
1986). This study aimed to investigate whether tsDCS has an effect on morphine-induced increase 
in the stretch responses in mice with SCI, during, 10, and 20 minutes after anodal tsDCS. Two 
groups of mice with SCI were used for this study: 1) an experimental group (n=5), received anodal 
tsDCS, 2) a non-stimulated, control group (n=2). The data show that morphine caused significant 
increase in muscle resistance, 35 min after injection (figure 3-8a). And although immediate anodal 
tsDCS resulted in reduction of morphine-induced muscle resistance in all three speeds, the 
reduction was not significant (figure 3-8b). Additionally, there was no significance between 
baseline and after 10 or 20 min of anodal tsDCS. Morphine-induced muscle resistance continued to 


































Figure 3-8    Anodal tsDCS reduces morphine-induced muscle resistance 
 
a, photographs showing fanning of the toes, and extension pattern of the paws. Right: strong 
resistance was manually felt. Also the tail was rigid. Bottom, example of force and RMS-EMG 
recorded before morphine (blue), after 35 min of morphine injection, and during the application of 
anodal tsDCS (red). b, morphine caused significant increase in muscle resistance 35 min after 
injection (n = 5) and this increase was reduced but is still significant by immediate application of 
anodal tsDCS (Friedman RM ANOVA, for speed 1, chi square = 14.8, p = 0.005; for speed 2, chi 
= 13.92, p = 0.008; for speed 3, chi square = 13.92, p = 0.008), *p < 0.05, Tukey test. There is no 
significance between baseline and after 10 or 20 min of anodal tsDCS. c, morphine caused steady 

















Effects of Direct Current Stimulation after MK-801 Injection 
MK-801 is an N-Methyl-D-aspartate (NMDA) receptor uncompetitive antagonist. It is 
used as anticonvulsant and anesthetic (Zuo et al., 2007). This study aimed to investigate tsDCS 
immediate effect on MK-801’s ability to reduce stretch resistance in mice with SCI. Two groups of 
mice with SCI were used for this study: 1) an experimental group (n=6), received anodal tsDCS, 2) 
a non-stimulated, control group (n=2). Data show that, compared to baseline, MK-801 caused 
significant reduction in peak muscle resistance 55 min after injection. While cathodal tsDCS had 
no effects on peak muscle resistance at all speeds, short term (1 min) application of anodal tsDCS 
reduced peak resistance at all speeds, significantly (figure 3-9a). Control group shows stable 
reduction of muscle peak resistance (figure 3-9b). These findings indicate that in SCI mice, anodal 



























 Figure 3-9    Anodal tsDCS further depresses Spasticity in the presence of MK801 in animals 
with SCI 
 
a, peak muscle resistance expressed as percent of baseline (n = 5,). MK801 causes significant 
reduction in peak muscle resistance 55 min after injection. Furthermore, short term (1 min) 
application of anodal tsDCS reduces peak resistance at all speeds. However, cathodal tsDCS has 
no effects on peak muscle resistance at all speeds. The difference in the mean values among the 
groups was tested using RM ANOVA, for speed 1, F = 25.5, p < 0.001; for speed 2, F = 8.3, p < 
0.001; for speed 3, F = 10.5, p < 0.001). To isolate the different groups, Holm-Sidak method was 
used; *p <0.001 compared to baseline; **p <0.002 compared to MK801.  b, control group (n = 2) 














Chapter 4  – Discussion 
Implantable vs. Surface Electrodes 
Characterized as an upper motor neuron and muscle tone disorder, spasticity is defined 
as a velocity-dependent increase in muscle resistance in response to passive stretching (Lance, 
1980). Management of muscle tone pathology is a crucial component of the rehabilitation process 
following SCI. This study investigated the immediate and long-term effects of tsDCS on spasticity, 
and the interaction of tsDCS with certain pharmacological agents, in order to understand the 
combined effects with tsDCS and possible tsDCS mechanisms of action. In this study, the 
immediate effects of tsDCS were examined using two different current-delivery settings: one 
utilized an implanted electrode and the other utilized a surface electrode. Initially, the electrode 
systems were implanted over the spinal column and the sciatic nerve of SCI mice according to 
Ahmed, 2016 (figure 2-3). And the systems were successfully used to provide anodal (spinal-to-
sciatic) or cathodal (sciatic-to-spinal) DCS. Anodal DCS treatment for 20 minutes using the 
implanted electrode system caused significant reduction in spasticity. This reduction was 
noticeable as soon as the anodal DCS started, and continued for an hour after the current stopped 
(figure 3-1). Although the implantable electrode system provided precise DCS to the spinal cord 
and sciatic nerve, implanting it was a tedious surgical procedure that involved possible risks of 
infections and post-surgical complications. Additionally, the procedure was time consuming and 
required extensive preparations before, during and after the surgery. Therefore, the effectiveness of 
surface electrodes, fabricated in our laboratory, in providing tsDCS was investigated. The surface 
electrodes were designed to be permanent components of the mouse holder (figure 2-1). 
Additionally, provided that anodal current possessed potential modulatory effect on spasticity, 






invasiveness. For the experiments in this study, not only the noninvasive setup was effective in 
reproducing data comparable to those obtained using the implanted system, but it eliminated the 
risks and complications associated with surgery, and the time needed for preparation and recovery. 
Additional important consideration in choosing over-skin electrodes over implantable electrodes is 
the practicality of their use in clinical settings. 
Expected Anodal Direct Current Stimulation Responses 
The concurrent reduction of spasticity in response to anodal tsDCS was anticipated in 
both setups of the immediate effect studies (figures 3-1 and 3-2): Eccles et al., 1962 found DC 
current to be an effective modulator of synaptic activity between the motor neurons and sensory 
afferents neurons within the spinal cord (Eccles et al., 1962). The anodal current on the spinal cord 
caused reduction in the amplitude of EPSP in motor neurons. Additionally, Ahmed, 2014 
investigated the modulatory effects of DC stimulation, and concluded that spinal-to-sciatic current 
reduced the muscle and nerve responses induced by steady and transit stretches (Ahmed, 2014b).  
Justification of Stretch Parameters 
To quantify responses to tsDCS via the stretch apparatus, the following parameters 
were used: peak muscle resistance, rising slope, EMG amplitude, and EMG area. Peak muscle 
resistance (calculated in gram of muscle resistance) is a sensitive parameter, reached at the end of 
the dynamic phase of the muscle stretch. The rising slope (calculated in gram/second) is a 
parameter that takes into consideration the variability of the rate of change along the resistance 
curve. EMG amplitude is an indicator of muscle activity; the higher the EMG amplitude, the 
higher the muscle resistance. EMG area is a parameter that takes into consideration the aggregated 






Neuronal vs. Passive Resistive Components 
Data analyzed for all parameters are the raw data (data collected while the animal is 
awake) minus those collected during isoflurane anesthesia. This method of data analyses was 
chosen to isolate values that represent the neuronal component of the stretch responses from 
passive resistance. The data collected during isoflurane, while the animal is fully anesthetized, 
represent muscle resistances that are attributed to passive forces only. The neuronal component of 
stretch resistance is greatly eliminated during isoflurane application. Therefore, when isoflurane 
values are deducted from the raw values, the difference will represent the neuronal component of 
the stretch responses only. The elimination of the passive muscle resistance is crucial to obtaining 
accurate data, since passive components can be altered due to SCI and repetitive stretching during 
testing. This method also makes it possible to quantify the portion of the stretch resistance that can 
be attributed to neuronal activity.  
Reliability of the Stretch Apparatus 
The SCI mouse model is ideal because of its availability, turnover speeds, ease of 
handling, and genetic closeness to humans. To investigate the effects of tsDCS on spasticity using 
this model, a tool to quantify stretch responses in mice was needed. However, there was no tool on 
the market made for this purpose. Therefore, a stretch apparatus was designed to accommodate the 
SCI mouse model, and then assembled in our laboratory. The sensitivity and validity of the 
apparatus have been verified through a number of uses: it detected differences between stretch 
responses in awake vs. isoflurane- anesthetized animals (figure 2-1). Additionally, control groups 
have been tested multiple times with no or negligible differences in subsequent recordings. The 
apparatus had also detected the differences between normal muscle stretch responses and those 






3-7), and MK-801 (figure 3-9). One feature of the apparatus proved to be of great importance to 
this study is its ability to detect stretch responses at different speeds. This feature was crucial for 
this study since spasticity is a velocity-dependent response. 
Rate-Dependent Depression is reduced in Spastic Mice 
Rate-Dependent Depression (RDD) is the attenuation of the h-reflex amplitude 
following repeated-sessions stimulations (Ishikawa et al., 1966; Lloyd and Wilson, 1957; Meinck, 
1976). RDD is reduced in spastic humans (Aymard et al., 2000; Nielsen et al., 1993), and animals 
(Hedegaard et al., 2015; Lee et al., 2014). In our RDD study, there were no significant differences 
in RDD reduction between the different frequencies in the sham group. There was significant 
difference between the control and sham groups at 5 Hz (figure 3-6 F). These findings support 
prior work correlating decreased RDD with increased spasticity after CNS injury (Lee et al., 2014). 
Effects of Ketamine on Rate-Dependent Depression 
In order to obtain RDD recordings, mice were anesthetized with a ketamine/xylazine 
cocktail (90/10 mg/kg, i.p). However, RDD recordings showed dependence on the level of 
ketamine anesthesia for the same animal, with increases in RDD in deeply anesthetized mice, and 
decreases in RDD when the same animal was under light anesthesia. These observations indicated 
that RDD was affected by ketamine concentrations in the body (figure 3-6). To eliminate the 
effects of deep ketamine anesthesia, the RDD protocol was performed while the animals were 
lightly anesthetized. The state of light anesthesia was accomplished when the animals reached 
precise values of heart and breathing rates. These values were reached approximately 45 minutes 
after anesthetic injection, where heart and breathing rates were 2 Hz and 0.5 Hz, respectively 






animals. This testing setup ensured that any RDD changes were caused by the tested variables, not 
the differences in ketamine levels. For future investigations, it is our recommendation to control 
for the effects of ketamine when used as anesthetic during RDD protocols. The process through 
which ketamine exerts its modulating effects on RDD has not been investigated. And the exact 
mechanism of its anesthetic activity is not well understood (Tyler et al., 2017). However, 
ketamine’s role as a nonspecific N-Methyl-D-aspartate receptor (NMDAR) antagonist has been 
well supported by research (Anis et al., 1983; Sleigh et al., 2014).  
MK-801 
Therefore, this experiment hypothesized that NMDAR may play a role in RDD in 
spastic mice. To test this hypothesis, MK-801 was used, which is an NMDAR specific antagonist, 
to block ketamine activity. Our results show significant reduction in stretch amplitudes following 
MK-801 injection (figure 3-9 A). These results are in agreement with prior work that explored the 
role and the potential therapeutic use of MK-801 in the treatment of spasticity (Brunson et al., 
2001; Li and Tator, 1999; Simpson et al., 1995). Notably, MK-801 blocked cathodal but not 
anodal stimulation effect on the stretch resistance in all three speeds. And it seems that anodal 
stimulation has an additive effect that is probably mediated by a different mechanism.  
Repeated Sessions of Anodal Stimulation Restore Rate-Dependent Depression in Spastic 
Mice 
The monosynaptic circuitry mediating the stretch reflex includes two types of neurons: 
The Ia afferent sensory neurons from the muscle spindle, and the alpha motor neuron that 
innervates the same muscle. The Ia afferent projects on the motor neuron to form an excitatory 






the H-reflex. The reduction of the H-reflex amplitudes associated with repeated stimulation of the 
stretch reflex pathway is the result of post-activation depression (Crone and Nielsen, 1989; 
Hultborn et al., 1996). 
The mechanisms that underlie post-activation depression involve a decrease in the 
probability of neurotransmitter quantal release from the Ia afferent due to its prior activation (Hirst 
et al., 1981; Kuno, 1964a; Kuno, 1964b; Lev-Tov and Pinco, 1992). Post-activation depression is 
functionally beneficial during voluntary movement, as it lowers the Ia afferent’s synaptic efficacy; 
therefore, prevent clonus and oscillations (Hultborn and Nielsen, 1998) Decreased post-activation 
depression; however, would increase the efficacy of the synapse, which in turn may lead to the 
hyper-excitability commonly associated with spasticity (Hultborn and Nielsen, 1998).  
RDD data were obtained from mice that underwent two types of stimulations, during 
tsDCS and after a week of repeated tsDCS (long-term) sessions. The results show significant RDD 
increases in the anode group compared to the sham group in both, the short-term tsDCS (data not 
shown) and long-term tsDCS (figure 3-6). These results can be explained in light of the 
modulating effects of DC current at the synaptic level. Anodal DC current, applied on the dorsum 
of the spinal cord, depolarizes the presynaptic terminals of Ia afferents, decreasing motor neurons’ 
EPSP. However, cathodal DC current hyperpolarizes the presynaptic terminals of the Ia afferents, 
increasing motor neurons’ EPSP (Eccles et al., 1962). Additionally, anodal current increases the 
frequency of miniature end-plate potentials due to enhanced spontaneous release (Del Castillo and 
Katz, 1954), likely causing depletion of presynaptic neurotransmitter.  
In summary, the stretch reflex circuit is partially capable of modulation via embedded 
mechanisms, such as the adjustment of spontaneous neurotransmitter release and post-activation 






functional decrease in the stretch reflex activity during voluntary movements. After SCI, the 
mechanisms are altered and the reflex pathway becomes hyperactive (Dietz and Sinkjaer, 2007; 
Little and Halar, 1985; Xu et al., 2015). However, using dorsal anodal stimulation after SCI, 
normal activity within the stretch reflex pathway was restored. Worth noting, the effect of anodal 
stimulation reported by Del Castillo & Katz, 1954 continued for few minutes after the stimulation 
was terminated. Our repeated stimulation study results show a carryover effect that lasted for 
weeks after the repeated-sessions anodal tsDCS was terminated. These findings have great 
implications for future studies aiming to investigate the mechanisms of the carryover effect at the 
cellular and molecular levels. 
Repeated Sessions of Direct Current Stimulation Result in Long-Term Effects on Spasticity 
This study was conducted to investigate the long-term effects of repeated-sessions 
tsDCS (7 days of 20-minute daily treatment) on spasticity in mice with SCI. Because spasticity is 
velocity-dependent, the TS was stretched at three different speeds: 18, 180, and 1800˚/s. Four data 
parameters thought to be important in assessing spasticity were measured. These parameters are as 
follows:  
1- The peak of active resistance 
2- The active slope 
3- The amplitude of EMG. 
4- The area of EMG 
For each of these components, on the active portion was including in the data analysis. 
The active component of each parameter represents the portion caused by neuronal activities, 
whereas the passive component represents the portion attributed to other elements, such as 






obtained while the animal was anesthetized with isoflurane from the raw amplitude value while the 
animal was awake, as explained in the methods section. Calculating the active values proved 
important when analyzing active peak and slope due to the inherent passive characteristics of the 
tissues involved in muscle contraction and joint stabilization, such as tendons and ligaments. 
Calculating active values was less important for EMG peak and area, because EMG activities are 
muscle responses to neuronal inputs, and only traces of EMG activities were present during 
isoflurane anesthesia (figure 2-1b, right –blue and green trances). The long-term tsDCS study data 
show that mice treated with anodal tsDCS had significant reductions in all four parameters 
compared to the other groups (figure 3-3). A plausible explanation to this finding involves the 
modulating effects of tsDCS on three components that directly affect the stretch reflex amplitude. 
These components are gamma motor neuron activity, Ia afferent-motor neuron synapse, and 
interneurons activity.  
The reduction of active muscle resistance with anodal tsDCS (figure 3-3a) can, at least 
partially, be attributed to the current’s ability to modify the activation threshold of muscle spindles. 
Matthews in 1972 found that the dynamic and static activation threshold of the muscle spindle 
could be controlled by two different types of motor neurons, the dynamic and static gamma 
efferents, respectively (Matthews, 1972). In this context, any activity modification of the gamma 
motor neuron caused by DC can have a direct impact on the activation threshold of the muscle 
spindle. This notion was confirmed when gamma efferents were found to exhibit decreased evoked 
activity with anodal current, and increased evoked activity with cathodal current (Ahmed, 2016).  
There are two defined mechanisms through which tsDCS can modulate gamma motor 
neurons activities: 1- direct modification of their membrane potential, 2- indirect modification of 






Ahmed, 2016; Bolzoni and Jankowska, 2015; Eccles et al., 1962). As explained by Ahmed 2016, 
gamma motor neurons have high input resistance due to their small size, which makes their 
membrane potentials less responsive to the electrotonic spread of tsDCS, possibly favoring the 
indirect presynaptic mechanism pathway.  
Direct Current-Induced Calcium Accumulation and Neuronal Plasticity 
Calcium is responsible for initiating and modulating a variety of activities within the 
cell, such as control of neurotransmitter release (Borst and Sakmann, 1996), long-term changes in 
synaptic transmission associated with memory (Dunwiddie and Lynch, 1979; Nicoll et al., 1989; 
Turner et al., 1982; Wang and Stelzer, 1996; Yasuda and Tsumoto, 1996), axonal regeneration 
(Hannila and Filbin, 2008; Henley et al., 2004), and activation of kinases that mediate gene 
expression (Bading, 1999; Li et al., 2016). One intriguing effect of tsDCS on neural tissue is its 
ability to redistribute calcium ions. DC current was found to increase calcium accumulations in 
axons, synaptosomes and segments of the spinal cord, where anodal current was more effective in 
the axons and cathodal current was more effective in synaptosomes (Wieraszko and Ahmed, 
2016). Early work investigating the effect of DC current on the monosynaptic stretch reflex 
junction shows that anodal current decreased the amounts of neurotransmitter release (Hubbard 
and Willis, 1962b), and cathodal current produced the opposite effect (Hubbard and Willis, 1962a). 
It is important to note that our tsDCS spinal electrode, located over the injured segment, should 
target different types of neurons and neuronal structures. These structures may include local 
interneurons and terminals of descending axons from higher spinal segments and the brain. 
However, importantly, the anodal current will have a direct effect on the Ia-motor neuron 
synapses, whether on those that survived the contusion injury, or the intact ones in the surrounding 






explained as a direct result of calcium influx, modulating the spontaneous quantal neurotransmitter 
release at the Ia-motor neuron synapses. The increased spontaneous transmitter release possibly 
depletes its presynaptic concentrations, causing depressed evoked potentials seen as reduced EMG 
activities during anodal tsDCS. 
Interestingly, the intracellular increased calcium mobilization may not only explain the 
short-term decreased spasticity found during anodal tsDCS, but can also explain the continuation 
of spasticity reduction in the long-term study. DC was found to continue modulating intracellular 
calcium concentrations for hours after its termination, possibly by increasing the activity of 
membrane-bound calcium channels, or activating and relocating calcium channels into the 
membrane (Wieraszko and Ahmed, 2016). Additionally, DC was found to exert synaptic 
modulations, where anodal current increased, and cathodal current decreased long-term 
potentiation (LTP) (Podda et al., 2016; Ranieri et al., 2012). Therefore, the mechanism by which 
DC exerts its long-term effect can alternatively be explained in light of synaptic plasticity (Monte-
Silva et al., 2013).  
Gabapentin 
Initially emerged as an antiepileptic drug (Johannessen and Ben-Menachem, 2006) and 
later used to treat neuropathic pain (Rosner et al., 1996), GABAp has a structure that is closely 
related to GABA (Rose and Kam, 2002). The mechanism through which GABAp exerts its action 
is not fully understood (Pfizer, 2014; Sills, 2006), and has been a subject of considerable debate for 
a number of reasons: despite early notion, GABAp does not bind GABAA (Rose and Kam, 2002) 
nor GABAB (Lanneau et al., 2001) receptors, and does not seem to affect the concentration, 
synthesis, or synaptic clearance of GABA (Pfizer, 2014). However, a strong body of evidence 






Dickenson, 2016), a subunit component of the voltage-gated calcium channel, responsible for its 
trafficking (Dolphin, 2012), membrane localization (Dolphin, 2013), and more importantly, 
modulation of calcium current density (De Waard and Campbell, 1995). GABAp functions as α2δ-
1 ligand, causing disruption of calcium channel trafficking (Hendrich et al., 2008) and reduction of 
calcium current. α2δ-1 subunits are upregulated in the sensory neurons of the dorsal root ganglion 
(DRG) after peripheral nerve injury (Bauer et al., 2009; Lana et al., 2014), and upregulated in the 
dorsal, but not the ventral, spinal cord, 30-40 days post-SCI (Boroujerdi et al., 2011). Over 
expression of α2δ-1 has been associated with the increased surface expression of calcium channels 
(Gurnett et al., 1996), and increased excitability of the dorsal spinal cord (Li et al., 2006; Nguyen 
et al., 2009). And in the presence of the astrocyte-secreted protein thrombospondin, in a process 
independent of the calcium channel current, α2δ-1 increases excitatory synaptogenesis (Eroglu et 
al., 2009). These facts underline the important function of α2δ-1 in modulating calcium current and 
neuronal plasticity. Prior work attributes spasticity, in part, to increases in presynaptic 
glutamatergic signaling, leading to motor neuron hyper-excitability (Kitzman, 2006). Therefore, 
the decreased peak resistance encountered after GABAp injection (figure 3-7a) can be explained as 
a reduction in presynaptic calcium current due to GABAp binding its α2δ-1 receptor, leading to 
decreased quantal glutamate release. The enhanced reduction of peak resistance induced by anodal 
tsDCS after GABAp injection (figure 3-7b) is probably due to depletion of the presynaptic 
glutamate reserves as a result of enhanced spontaneous transmitter release (See Chapter 4  on DC-
induced calcium accumulation and neuronal plasticity). 
Morphine 
Systemically administered opiates, such as morphine, cause dose-dependent muscular 






action is not clear. A number of brain structures have been implicated in opioid-induced rigidity, 
such as the basal ganglia (Slater and Starkie, 1987), locus coeruleus (Lui et al., 1989), thalamus 
(Ossowska et al., 1986), periaqueductal gray, and nucleus raphe pontis (Weinger et al., 1991). It 
has been suggested that morphine interacts with the dopaminergic receptors in the striatum, 
reducing the amounts of released dopamine (Kuschinsky and Hornykiewicz, 1972), through a 
mechanism similar to that of Parkinson’s disease (PD). Though the reduction in the levels of 
dopamine in PD are caused by loss of dopaminergic nigrostriatal neurons, (Korchounov et al., 
2010), morphine rigidity is likely due to inhibition of tyrosine hydroxylase, the enzyme that 
catalyzes the rate-limiting step in dopamine synthesis (Freye, 1976). Opioid rigidity was also 
explained as a result of the interaction with the opiate binding receptors in the striatum, 
particularly the mu (μ) type (Goldblum and Loew, 1991; Vankova et al., 1996) located in the head 
of the caudate nucleus (Havemann et al., 1980). Opioid (μ) receptors are not exclusive to the brain. 
They are abundant in the spinal cord and DRG where they are implicated in the local nociceptive 
depressive effects of opioids, segmentally and peripherally (Besse et al., 1990; Stein, 2003). It 
seems that the opioid-induced anti-nociceptive spinal depression is independent of the opioid 
effect on the brain, and independent of the influence of the descending connections (Chen and Pan, 
2006). However, this may not be the case for opioid-induced rigidity, where supraspinal centers 
plays a major role (Kuschinsky et al., 1977; Vankova et al., 1996). Supraspinal involvement had 
been confirmed via spinalization experiments that abolished morphine-induced rigidity, where 
descending influence excited the extensor alpha motor neurons (Kuschinsky et al., 1977) and 
inhibited the flexor alpha motor neurons (Seeber et al., 1978).  
The results show palpable morphine-induced extensor muscle rigidity, 35 minutes after 






stretch speeds compared to baseline (figure 3-8b). Although the immediate response to anodal 
tsDCS was a reduction in active peak resistance, the resistance was still significant compared to 
baseline. However, 10 minutes after anodal tsDCS, the morphine-induced resistance was no longer 
significant, and the reduction continued for 20 minutes after the initial application of anodal tsDCS 
(figure 3-8b).  
The increased peak resistance of the TS (an ankle extensor) following morphine 
injection (figure 3-8b) confirms the findings reported by Seeber et al. (1978). And although the 
anticipated reduction in the tibialis anterior muscle tone (ankle flexor) could not be assessed due to 
stretch apparatus limitations, it is assumed to be present. Since the tibialis anterior muscle is a TS 
antagonist, its morphine-induced tone reduction can be viewed as an added force that can enhance 
the peak resistance of the TS stretch. So, two forces are contributing to the increased TS stretch 
peak resistance: 1- its morphine-induced rigidity, and 2- the force added by the morphine-induced 
inhibition of the tibialis anterior muscle. The results show the effectiveness of anodal tsDCS as 
modulator of morphine-induced rigidity by overcoming these combined forces. And although the 
exact mechanisms of morphine-induced rigidity are not yet fully understood, it seems that anodal 
tsDCS reduces morphine-induced extensor muscle rigidity, possibly via decreasing synaptic 
activity (See Chapter 4 on DC-induced calcium accumulation and neuronal plasticity). 
Locomotion Recovery 
Impaired locomotion is one of the most debilitating consequences of SCI. Great body 
of research has been dedicated to finding methods to increase the motor function of patients after 
SCI. In this study, the long-term effects of tsDCS on spasticity, recovery of gait and skilled 
locomotion were assessed. Specific gait parameters that reflect possible tsDCS-induced changes in 






abnormalities is well documented in research (Adams and Hicks, 2005; Bravo-Esteban et al., 2013; 
Faist et al., 1999; Lamontagne et al., 2001). For example, in healthy humans, continuous 
modulation of the stretch reflex is essential for maintaining the proper progression of the gait cycle 
(Capaday and Stein, 1986; Crenna and Frigo, 1987). However, after CNS injury, this modulation 
suffers different levels of impairment, depending on the extent of spasticity, and the origin of 
injury, cerebral or spinal (Faist et al., 1999). Additionally, the level of SCI and the severity of 
spasticity have a major impact on the effectiveness of walking, and can predict patterns of gait 
abnormalities (Krawetz and Nance, 1996). Moreover, spasticity slows locomotion and interferes 
with skilled movements due to co-contraction (Dyer et al., 2011), and associative movements 
(Mayer, 2002). 
In this study, the data clearly show that repeated anodal tsDCS resulted in Long-term 
amelioration of spasticity, as indicated by the significant decreases in active peak resistance, active 
resistance slope, and EMG activities (figure 3-3c). However, it was important to investigate 
whether the anodal-induced reduction in spasticity can be linked to improved functionality. As 
discussed earlier, after SCI, spasticity interferes with the components of the gait cycle; therefore, 
significant reductions in spasticity should have normalizing effects on at least some of these 
components. This investigation concentrated on parts of the cycle that involve stretches of the TS 
during various parts within the stance phase – when the foot is in contact with the ground. In 
stance, it is ideal to assess the effects of spasticity on gait, as the TS stretch at different velocities, 
which is on par with the definition of spasticity coined by Lance (Lance, 1980).  
To assess the effects of tsDCS on gait (figure 3-4), three locomotion-related parameters 
were investigated: rising slope, peak paw area, and falling slope. These parameters were chosen 






of the rising slope marks the initiation of the stance phase, when the animal’s heel strikes the 
ground. The rest of the rising slope corresponds to the progressive lowering of the foot to the 
ground, as the animal shifts body weight (the loading response) to that foot. The shifting continues 
till midstance – a point at the middle of the stance phase with the foot flat on the ground. At 
midstance, the second parameter, the peak paw area, was measured. The falling slope, however, 
follows the end of midstance, and begins as heel starts of elevate (heel off), and continues as the 
foot gradually prepares for push off to propel the animal forward.  
It is important to note that spastic animals show tip-toeing paw placement during the 
heel strike and will have a decreased peak paw area. They will also have a lower rising and falling 
slops due to the increased transition time caused by spasticity. Consequently, changes in the peak 
paw area, rising slope, or falling slope can be directly attributed to modulation of the severity of 
spasticity. In order to appreciate this relationship, one must remember that the slopes provide 
important temporal information regarding the lengthening and contractibility of the TS during 
different points of stance. For example, an increased falling slope after anodal tsDCS signifies a 
faster transition from midstance to push-off. During most of the stance phase, the TS undergo 
progressive lengthening, as the ankle flexes, and the body moves forward. In spastic animals, this 
lengthening triggers locomotion-interfering reflexive contractions due to the impaired reflex 
modulation associated with spasticity (Faist et al., 1999). Therefore, the significant increases in the 
falling and rising slopes following anodal treatment shown by the data (figure 3-4d, middle and 
lower graphs), indicate enhanced transition, and decreased transition time. Additionally, the peak 
paw area for the same animals also increased during midstance for both slow and fast speeds 






These data collaborate with our observations during locomotion testing, as the anodal-
treated animals gradually changed their tip-toeing paw placements during midstance to foot-flat 
placements. Considering that the anodal-treated animals didn’t receive any additional locomotion 
training compared to the animals of the other groups, these findings show genuine intrinsic plastic 
changes. Therefore, it is safe to deduce that increased paw area signifies improved modulation of 
the stretch reflex of the foot and toe flexors in response to passive stretches from the ground. And 
that the increased rising and falling slopes signify improved modulation of the stretch reflex in 
response to stretches of the TS during the stance phase.  
Our data show consistency with respect to the effect of anodal tsDCS as a stretch reflex 
circuit modulator. As explained earlier, long-term anodal tsDCS restored RDD (figure 3-6e and f). 
It also reduced stretch reflex-induced peak resistance, resistance slope and EMG activity, acutely 
and chronically, at all different tested speeds, after SCI (figure 3-3). These findings point to a 
modulated stretch reflex circuit model that is capable of receiving and executing input signals from 
multiple CNS sources. For example, the new modulatory properties of the stretch reflex circuit are 
not only capable of adjusting to inputs received from the locomotion-mediating central pattern 
generators, but are also capable of adjusting to the skilled-movement commands from higher CNS 
centers. This was confirmed by the improvement in skilled locomotion scores exhibited by the 
anode-treated animals (figure 3-5b and c). 
Study Weaknesses 
The animals of the immediate effect study were evaluated for only one hour after treatment, 
with no subsequent assessments. Follow up evaluations should have been conducted to find a 
threshold in the treatment protocol (the least number of treatment session) where the immediate 






Future Studies  
1- Follow up investigations would allow us to quantify the amount of time it takes for 
the electrophysiological effect of tsDCS to dissipate, and assess the amount of time needed for the 
initiation and completion of protein synthesis necessary for the long-term effect changes.  More 
evaluations at different set points during the treatment protocol can reveal the long-term effect 
threshold. 
2- Assuming that LTP-, LTD-like mechanisms are behind the long-term changes 
encountered post-tsDCS, a subsequent study will be needed to assess protein changes and map 
their pathway(s). The application of a protein synthesis inhibitor, anisomycin, within three hours of 
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